SURAKSHA vs THYROCARE: Stock Comparison
Thyrocare Technologies Ltd is the larger company by market capitalisation. Suraksha Diagnostic Ltd shows a lower P/E and faster revenue growth, while Thyrocare Technologies Ltd shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SURAKSHA leads 4; THYROCARE leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SURAKSHA | THYROCARE |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Service Provider | Healthcare Service Provider |
Price
| Metric | SURAKSHA | THYROCARE |
|---|---|---|
| Live Price | ₹316.15 | ₹596.1 |
| Day Change | -2.15% | 2.07% |
| Volume | 60,667 | 2.05 L |
| 52-Week High | ₹333 | ₹1,610 |
| 52-Week Low | ₹224.1 | ₹342.55 |
| Distance from 52W High | -5.06% | -62.98% |
Valuation
| Metric | SURAKSHA | THYROCARE |
|---|---|---|
| Market Cap | ₹1,649 Cr | ₹9,491 Cr |
| P/E Ratio | 47.42x | 52.89x |
| P/B Ratio | 6.93x | 15.93x |
| EPS | ₹6.87 | ₹11.1 |
| Book Value | ₹47 | ₹36.8 |
| Dividend Yield | 0.16% | 1.5% |
Growth
| Metric | SURAKSHA | THYROCARE |
|---|---|---|
| Revenue Growth (TTM YoY) | 31.2% | 19.7% |
| EPS Growth (TTM YoY) | -5.4% | 116.3% |
| Qtr Sales Growth | 20.8% | 24.3% |
| Qtr Profit Growth | 38.4% | 34.1% |
Profitability & Leverage
| Metric | SURAKSHA | THYROCARE |
|---|---|---|
| ROE | 14.1% | 28.4% |
| ROCE | 17% | 35.4% |
| Net Margin | 10.37% | 19.67% |
| Operating Margin | 31.4% | 32.1% |
| Debt to Equity | 0.53x | 0.09x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | SURAKSHA | THYROCARE |
|---|---|---|
| Promoter Holding | 49.1% | 60.92% |
| FII Holding | 13.47%▲ 0.01 pp | 5.44%▲ 0.07 pp |
| DII Holding | 23.23%▲ 0.09 pp | 20.92%▼ 0.07 pp |
| Public Holding | 14.21%▼ 0.1 pp | 12.72%▲ 0.01 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Suraksha Diagnostic Ltd and Thyrocare Technologies Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.